Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

5 Nov 2020 13:23

RNS Number : 4187E
Feedback PLC
05 November 2020
 

 

Feedback plc

 

Result of Annual General Meeting

 

London, UK, 5 November 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that at its annual general meeting held earlier today, all resolutions were duly passed on a poll. The proxy voting results of the resolutions are included below.

 

 

Resolutions

Votes For*

% of votes cast**

Votes Against

% of votes cast**

Votes Withheld**

Total votes cast**

 

1. To receive and adopt the annual report and accounts for the year ended 31 May 2020

504,134,927

100.00%

-

0.00%

22,000

503,044,792

 

2. To elect Adam Denning as a director

504,152,622

100.00%

3,305

0.00%

1,000

503,065,534

 

3. To elect Philipp Prince as a director

479,902,622

95.19%

24,253,305

4.81%

1,000

503,065,534

 

4. To re-elect Simon Sturge as a director

504,152,486

100.00%

3,441

0.00%

1,000

503,065,670

 

5. To appoint Price Bailey LLP as auditors of the Company

504,118,963

99.99%

36,964

0.01%

1,000

503,099,193

 

6. To authorise the directors to allot relevant securities equivalent to up to two thirds of the Company's issued share capital, subject to certain conditions

504,027,372

100.00%

3,305

0.00%

126,250

502,940,284

 

7. To authorise the directors to allot relevant securities equivalent to up to 10 per cent. of the Company's issued share capital on a non-pre-emptive basis subject to certain conditions

478,945,731

95.01%

25,135,091

4.99%

76,205

502,990,429

 

Notes:

* "Votes For" include votes giving the Chairman discretion.

** "Votes Withheld" are not votes in law and do not count in the number of votes counted for or against a resolution, or towards the total votes cast.

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

 

 

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

 

 

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936

 

 

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686

 

 

Notes to Editors

 

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.

 

Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGXELFBBFLLFBL
Date   Source Headline
19th Dec 20062:36 pmRNSInterim Results
19th Oct 20063:46 pmRNSHolding(s) in Company
17th Oct 20069:53 amRNSDirector/PDMR Shareholding
28th Sep 20065:25 pmRNSPosting of accounts
27th Sep 20067:01 amRNSFinal Results
18th Apr 20064:55 pmRNSHolding(s) in Company
21st Feb 20061:04 pmRNSHolding(s) in Company
17th Jan 20068:28 amRNSHolding(s) in Company
14th Dec 20057:01 amRNSInterim Results
30th Nov 20052:34 pmRNSHolding(s) in Company
23rd Sep 20052:53 pmRNSConversion of Securities
10th Aug 20057:01 amRNSFinal Results
21st Jul 20055:06 pmRNSHolding(s) in Company
11th Jul 20055:21 pmRNSConversion of Securities
14th Apr 200512:23 pmRNSConversion of Securities
16th Mar 20051:07 pmRNSDisposal
28th Feb 20055:04 pmRNSCirc re. EGM
24th Feb 200512:49 pmRNSStatement re Pension Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.